News

Filter

1 to 9 of 48 results

US market for asthma drugs set to reach $14 billion by 2020

US market for asthma drugs set to reach $14 billion by 2020

18-03-2015

The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14…

Arnuity ElliptaFloventGlaxoSmithKlineMarkets & MarketingPharmaceuticalRelvarRespiratory and PulmonaryUSA

Actavis confirms Appeals Court grants injunction over generic Pulmicort Respules

Actavis confirms Appeals Court grants injunction over generic Pulmicort Respules

13-03-2015

Ireland-headquartered generics major Actavis has confirmed that the US Court of Appeals for the Federal…

ActavisAstraZenecaGenericsLegalPulmicort RespulesRespiratory and PulmonaryUSA

COPD program sponsored by AstraZeneca will create more opportunities for research

COPD program sponsored by AstraZeneca will create more opportunities for research

05-03-2015

The USA-based COPD Foundation has announced an initiative to accelerate research for chronic obstructive…

AstraZenecaPharmaceuticalResearchRespiratory and PulmonaryUSA

FDA formally accepts Actelion's NDA for Uptravi

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

05-02-2015

Anglo-Swedish pharma major AstraZeneca has acquired the rights to Ireland-headquartered generics major…

ActavisAstraZenecaDalirespFinancialPharmaceuticalRespiratory and PulmonaryTudorza PressairUSA

1 to 9 of 48 results

Back to top